Study claims anti-aging efficacy of Elastatropin

By Simon Pitman

- Last updated on GMT

Related tags: Aging, Senescence, Gerontology

A study carried out by anti-aging researcher Dr. Steven Lamm claims
that an anti-aging cream developed by US-based DermaPlus that
contains Elastatropin has 'very positive results'.

DermaPlus says the results of a six-week study of 25 women and 3 men twice a day applying DermaLastyl-B, an Elastatropin-based face cream, shows that treatment had an impact on the texture, elasticity, hydration, moisturization and appearance of skin.

The company says that extensive research into elastin - a key element to maintain skin elasticity and to prevent wrinkles - has led to the development of Elastatropin. The ingredient has been genetically engineered from laboratory organisms in an effort to replicate human elastin.

This synthesized human elastin is said to hold the skin cells together into tissues providing support and flexibility and helping to fight visible signs of aging such as wrinkles and a general lack of skin elasticity.

Although it has long been known that the depletion of the skin's elastin levels does affect the skins overall elasticity and tendency to wrinkle, discovering a means of replenishing elastin levels through topical applications has been a constant challenge to dermatologists.

Dr. Lamm, who is an assistant professor of medicine at New York University School of Medicine and an authority on the aging process explained about the method he undertook to test the face cream.

"I started this as an initial phase Skin Tolerance Study of DermaLastyl-B face cream, and was encouraged to find that 96 per cent of my study subjects had such positive results after six weeks,"​ he said.

He added his belief that a generally more youthful look was attributable to the Elastatropin, which had behuge to replenish the skin's elastin. Over time he believes that this treatment could be used to slow the onset of wrinkles and facial sagging.

But Dr. Lamm believes that further studies are essential over a longer period of time in order to prove the ingredient's true efficacy.

"I recommend a more extensive scientific evaluation so as to observe the effects over an extended period. Let's find out how well it actually reduces wrinkles, as some long term users claim,"​ Lamm said.

The short-term study also revealed that over 90 per cent of those taking part in the study reported increased skin hydration and moisturization but that the product was also light and non-greasy, enabling them to put make-up on over the cream.

Interestingly the study also revealed that 83 per cent of red-heads using the cream reported that their skin had lightened in tone during the course of the six-week treatment, indicating that it also is a possible means of reversing sun damage in those individuals with the lightest skin colors.

Related topics: Skin Care

Related news

Show more

Related products

show more

Tagra: Stabilizing Retinol to Rejuvenate Skin

Tagra: Stabilizing Retinol to Rejuvenate Skin

Tagra Biotechnologies | 09-Jun-2022 | Product Presentation

Retinol is widely regarded in the cosmetics industry as a golden ingredient for ageless skin. Yet, it tends to lose its efficacy quickly due to a variety...



Lubrizol Life Science | 26-May-2022 | Product Presentation

Telophi™ biotech ingredient is a biotechnological extract that protects telocytes and proliferating epidermal stem cells from psychological stress to preserve...

Protect your skin daily from U.V

Protect your skin daily from U.V

Robertet Health & Beauty | 03-May-2022 | Technical / White Paper

Able to increase skin resistance to UV exposure and to fight both UVA and UVB associated side-effects, Holimel® is a new solution for daily skin protection...

Related suppliers

Follow us


View more